Alternative inflammasome activation enables IL-1β release from living cells
- PMID: 27842238
- PMCID: PMC5894802
- DOI: 10.1016/j.coi.2016.10.007
Alternative inflammasome activation enables IL-1β release from living cells
Abstract
Classical modes of NLRP3 activation entail a priming step that enables its activation (signal 1) and a potassium efflux-dependent activation signal (signal 2) that triggers pyroptosome formation and pyroptosis, a lytic cell death necessary for IL-1β release. Opposing to that, human monocytes engage an alternative NLRP3 inflammasome pathway in response to LPS that proceeds in the absence of signal 2 activation and enables IL-1β secretion without pyroptosis. This specifically relies on Caspase-8 to propagate signaling to NLRP3, leading to inflammasome activation in absence of pyroptosome formation. Here, we summarize the current knowledge about alternative inflammasome activation, discuss potential extensions of this signaling entity beyond LPS-dependent activation, speculate about its role in tissue homeostasis and sterile inflammation and highlight the implications of pyroptosis-independent IL-1β secretion.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures

References
-
- Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. - PubMed
-
- Dinarello CA. A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur J Immunol. 2011;41:1203–1217. - PubMed
-
- Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–665. [•• This is one of three reports identifying a crucial role for GSDMD in pyroptosis regulated by proteolytic cleavage by inflammatory caspases.] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources